Ga naar de inhoud Ga naar de footer

Nieuws

All
General
Regulated
Transparency/Denominator

Nieuws, Regulated

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC

Nieuws, Regulated

Oxurion ends discussions regarding previously announced preclinical transaction and continues integration of a strategic clinical partner

november 3, 2025

Nieuws, Regulated

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC

oktober 23, 2025

Nieuws, Regulated

Oxurion Receives Amended Transparency Notifications from Atlas Special Opportunities II LLC

oktober 17, 2025

Nieuws, Regulated

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC

oktober 16, 2025

Nieuws, Regulated

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas

oktober 15, 2025

Nieuws, Regulated

Oxurion signs letter of intent for the contemplated acquisition of a CRO with strong complementarity to Axiodis

oktober 13, 2025

Nieuws, Regulated

Oxurion provides an update related to its investment strategy in digital assets

oktober 9, 2025

Nieuws, Regulated, Transparency/Denominator

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas

oktober 3, 2025

Nieuws, Regulated

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC

oktober 2, 2025

Nieuws, Regulated

Oxurion Publishes First Half 2025 Results

september 30, 2025

General, Nieuws

Axiodis CRO, the French subsidiary of the Oxurion Group, announces a dual AI-driven strategic initiative to transform clinical trials

september 16, 2025

Nieuws, Regulated

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC

september 8, 2025

Nieuws, Regulated

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC

september 1, 2025

Nieuws, Regulated

Oxurion confirms progress in negotiations related to its treasury diversification strategy; closing of the transaction expected before September 25, 2025

september 1, 2025

Nieuws, Regulated

Oxurion Receives Transparency Notifications from UBS Group AG

augustus 7, 2025

Nieuws, Regulated

Oxurion Ends R&D Program in Geographic Atrophy and Refocuses on New CRO Activities

augustus 7, 2025

Nieuws, Regulated

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC

augustus 6, 2025

Nieuws, Regulated

Oxurion announces it obtained an improved indicative €30 million financing offer to initiate its plan to diversify by allocating part of its treasury into digital assets

augustus 4, 2025

General, Nieuws, Regulated

Oxurion completes the acquisition of Axiodis CRO and accelerates the structuring of its European clinical data platform

augustus 4, 2025

Oxurion Receives Transparency Notifications from UBS Group AG

augustus 7, 20250Opmerkingen

Oxurion Ends R&D Program in Geographic Atrophy and Refocuses on New CRO Activities

augustus 7, 20250Opmerkingen

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC

augustus 6, 20250Opmerkingen

Oxurion announces it obtained an improved indicative €30 million financing offer to initiate its plan to diversify by allocating part of its treasury into digital assets

augustus 4, 20250Opmerkingen

Oxurion completes the acquisition of Axiodis CRO and accelerates the structuring of its European clinical data platform

augustus 4, 20250Opmerkingen

Oxurion Receives Amended Transparency Notification from Atlas Special Opportunities II LLC

juli 30, 20250Opmerkingen

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas

juli 30, 20250Opmerkingen

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas

juli 25, 20250Opmerkingen

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas

juli 24, 20250Opmerkingen

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas

juli 23, 20250Opmerkingen

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC

juli 23, 20250Opmerkingen

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC

juli 22, 20250Opmerkingen

Oxurion plans to launch a treasury diversification strategy into digital assets under a €10M indicative agreement with its main investor

juli 22, 20250Opmerkingen

Oxurion Secures Financing for the Acquisition of Axiodis CRO and Targets Closing on August 1, 2025

juli 17, 20250Opmerkingen

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC

juli 15, 20250Opmerkingen

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC

juli 14, 20250Opmerkingen

Oxurion Announces the Fulfilment of the Second Condition Precedent in the Acquisition of Axiodis

juli 10, 20250Opmerkingen

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas

juli 4, 20250Opmerkingen

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC

juli 3, 20250Opmerkingen

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC

juni 30, 20250Opmerkingen

Newest posts Older posts